sofosbuvir has been researched along with Depression in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Farcomeni, A; Gioia, S; Nardelli, S; Ridola, L; Riggio, O; Rosati, D | 1 |
| Abdel Moez, AT; Al Balakosy, AM; El Hawary, YA | 1 |
| El Kassas, M; Farag, A; Shepherd, A; Youssef, NF | 1 |
3 other study(ies) available for sofosbuvir and Depression
| Article | Year |
|---|---|
Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms.
Topics: Aged; Antiviral Agents; Anxiety; Benzimidazoles; Depression; Female; Fluorenes; Hepacivirus; Hepatitis C; Humans; Male; Middle Aged; Psychological Tests; Quality of Life; Self Report; Severity of Illness Index; Sofosbuvir; Treatment Outcome; Uridine Monophosphate | 2019 |
Can successful treatment by direct-acting antivirals improve depression in chronic HCV patients?
Topics: Aged; Antiviral Agents; Depression; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Sofosbuvir; Sustained Virologic Response | 2021 |
Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt.
Topics: Antiviral Agents; Anxiety; Depression; Drug Therapy, Combination; Egypt; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Patient Reported Outcome Measures; Prospective Studies; Quality of Life; Social Support; Sofosbuvir | 2017 |